BEAM

#1651
Beam Therapeutics Inc. Common Stock
30.58 USD
+1.33%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
30.44
30.89
年范围
15.35
36.44
日变化
+1.33%
每月变动
+18.99%
6个月变化
+19.17%
年变化
+82.24%
前一天收盘价
30.18
开盘价
30.85
买价
卖价
最低价
30.44
High
30.89
交易量
277
展开完整图表

Financials

概览 声明 统计 股息
每季度 年度
  • Market Capitalization 3.11 B
  • Employee 511
  • Founded 2017
  • CEO John Evans
  • Website www.beamtx.com
  • Headquarter Delaware, United States
  • FIGI BBG00KXC8646
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
-34.22
市销率
19.62

Beam Therapeutics Inc

Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks.

新闻